| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 468.89M | 709.35M | 1.09B | 1.19B | 1.01B |
| Gross Profit | 100.65M | 140.74M | 233.49M | 242.73M | 187.30M |
| EBITDA | -38.14M | -38.25M | -61.01M | -94.55M | -146.97M |
| Net Income | -54.13M | -63.66M | -102.80M | -128.39M | -194.44M |
Balance Sheet | |||||
| Total Assets | 316.17M | 383.21M | 540.80M | 778.31M | 880.57M |
| Cash, Cash Equivalents and Short-Term Investments | 42.66M | 72.72M | 159.65M | 290.94M | 460.78M |
| Total Debt | 50.06M | 66.38M | 209.55M | 380.39M | 614.99M |
| Total Liabilities | 87.79M | 122.33M | 315.85M | 529.96M | 752.88M |
| Stockholders Equity | 189.81M | 218.68M | 178.28M | 199.18M | 82.67M |
Cash Flow | |||||
| Free Cash Flow | -70.14M | -25.99M | -55.92M | -150.60M | -254.00M |
| Operating Cash Flow | -66.83M | -25.43M | -54.07M | -147.50M | -247.49M |
| Investing Cash Flow | 24.60M | 47.81M | 46.50M | 21.15M | -184.42M |
| Financing Cash Flow | 8.15M | -33.13M | -76.66M | 2.00M | 648.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $39.46B | 9.20 | 13.68% | 3.37% | 16.54% | -3.61% | |
63 Neutral | $10.57B | 52.61 | 59.58% | ― | 9.80% | -46.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | $4.97M | -0.90 | ― | ― | -16.89% | 31.24% | |
44 Neutral | $6.65M | -0.39 | ― | ― | -35.95% | 26.08% | |
44 Neutral | $22.53M | 0.13 | 12.11% | ― | 570.49% | ― | |
39 Underperform | $5.51M | -2.12 | -25.20% | ― | -34.36% | 59.23% |
On February 11, 2026, Boqii Holding Limited announced that Senior Vice President Chao Guo resigned from his position effective immediately, citing personal reasons and affirming that the decision did not stem from any disagreement with the company. The departure removes a member of the senior leadership team but, given the company’s clarification on the absence of internal conflict, the move appears to be a routine executive transition rather than a signal of strategic or governance upheaval.
The filing also notes that this disclosure will be incorporated by reference into Boqii’s existing U.S. shelf registration statement, ensuring that investors operating in U.S. markets have up-to-date information on changes in the firm’s management. This step underscores the company’s ongoing compliance with U.S. securities regulations and provides stakeholders with formal notice of the leadership change within its executive ranks.
The most recent analyst rating on (BQ) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Boqii Holding stock, see the BQ Stock Forecast page.
On January 5, 2026, Boqii Holding reported unaudited financial results for the first half of fiscal 2026, covering the six months ended September 30, 2025, showing that total revenues declined 16.7% year-on-year to RMB207.9 million as the company prioritized profitability over sales volume, with GMV also decreasing to RMB376.4 million. Despite weaker topline performance in a challenging consumption environment, Boqii significantly improved its profitability metrics: gross margin rose 520 basis points to 25.9%, operating expenses fell 10.2%, and net loss narrowed 75.1% to RMB7.4 million, aided by a stronger focus on higher-margin private-label products, supply-chain optimization that cut fulfillment costs, and cost reductions including staff layoffs and lower rental expenses; EBITDA loss also shrank sharply and the company exited its involvement in Nanjing Xingmu’s operations effective April 1, 2025, underscoring a strategic shift toward leaner, higher-margin operations that may bolster its competitive positioning in China’s pet economy.
The most recent analyst rating on (BQ) stock is a Sell with a $2.00 price target. To see the full list of analyst forecasts on Boqii Holding stock, see the BQ Stock Forecast page.
On December 4, 2025, Boqii Holding Limited’s variable interest entity, Shanghai Guangcheng, entered into an equity interest repurchase agreement with Nanjing Xingmu Biotechnology Co., Ltd. and its founders. The agreement involves the repurchase of a 14.5% equity interest in Nanjing Xingmu for RMB 12.5 million, to be paid in installments. This transaction is expected to lead to the termination of existing contractual arrangements, impacting the company’s financial consolidation practices.
The most recent analyst rating on (BQ) stock is a Sell with a $2.00 price target. To see the full list of analyst forecasts on Boqii Holding stock, see the BQ Stock Forecast page.